Skip to content
lifestyle.bossesmag.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Evaxion
Evaxion announces business update and second quarter 2026 financial results
August 20, 2026
Evaxion expands and refocuses R&D pipeline with EVX-05, an AI-designed off-the-shelf brain cancer vaccine program
August 17, 2026
Evaxion to announce business update and second quarter 2026 financial results on August 20, 2026
August 14, 2026
Evaxion to present three-year clinical efficacy data for personalized cancer vaccine EVX-01 at the ESMO Congress 2026
July 17, 2026
Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1
July 12, 2026
Evaxion to present new preclinical data for cytomegalovirus vaccine candidate EVX-V1 at the International Herpesvirus Workshop
July 1, 2026
Evaxion receives Prix Galien UK Award for Best digital health solution
June 12, 2026
Evaxion presents new preclinical data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia
June 11, 2026
Evaxion to present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, at the EHA 2026 Congress
May 29, 2026
Evaxion announces business update and first quarter 2026 financial results
May 28, 2026
1
2
3
Next Page
→